期刊文献+

人脑胶质瘤组织HIF-1α和COX-2及CD105蛋白表达与临床病理学关系的研究 被引量:6

Relationship between the expressions of HIF-1α,COX-2 and CD105 in human glioma tissues and clinicopathology
下载PDF
导出
摘要 目的:探讨缺氧诱导因子-1α(HIF-1α)、环氧化酶-2(COX-2)及CD105在人脑胶质瘤组织中的表达及与临床病理特征的关系。方法:应用免疫组化SP法检测70例胶质瘤和10位正常人脑组织中HIF-1α、COX-2和CD105的表达,并测定CD105标记的MVD。结果:1)胶质瘤组织中HIF-1α、COX-2和CD105蛋白的阳性表达率分别为64.3%、61.4%和74.3%,明显高于正常人脑组织。2)HIF-1α、COX-2表达和MVD与胶质瘤病理分级密切相关。3)胶质瘤组织中HIF-1α和COX-2蛋白表达的一致符合率为70.35%,且两者表达呈正相关,r=0.5837,P=0.004。4)HIF-1α和COX-2阳性表达组的MVD(35.87±4.55和36.00±4.57)均高于阴性表达组(29.19±4.69和29.48±4.71),P值均为0.0000;两者均为阳性表达时的MVD(36.22±4.62)最大,明显高于其他各组(33.75±3.59和28.29±4.33),P=0.0001;两者表达均与MVD呈正相关,r值分别为0.5405和0.4652,P值分别为0.005和0.014。结论:HIF-1α、COX-2和CD105过表达可能在胶质瘤的恶性进展中发挥重要作用,并与肿瘤血管形成密切相关,三者的联合检测可更准确地揭示胶质瘤的生物学特性。 OBJECTIVE: To investigate the relationship be tween the expressions of HIF-1α, COX-2 and CD105 in human gliomas and clinicopathological features. METHODS:The expressions of HIF-1α, COX-2 and CD105 were examined by SP immunohisto chemical staining in 70 human glioma specimens and 10 normal human brain tissue specimens, and MVD labeled by CD105 were measured. RESULTS: 1) The positive expression rates of HIF-1α, COX-2 and CD105 proteins in gliomas (64.3%,61.4%,74.3%) were significantly higher than those of normal human brain tissues. 2) The expressions of HIF-1α, COX-2 and MVD were associated with the pathological grading of gliomas. 3)The expression conformation rate of HIF-1α and COX-2 was 70.35%, and there was a positive correlation between the expressions of HIF-1α and COX-2, r=0.583 7,P=0.004. 4)The MVD values in HIF-1α and COX-2 positive groups [(35.87 ± 4.55) ; (36.00±4.57)] were significantly higher than those in negative groups, respectively [(29. 19±4.69) ;(29.48±4.71)],and P was both 0.000 0, The MVDvalue (36.22±4.62) in both HIF-1α positive and COX 2 positive group was significantly higher than those in the other subgroups [(33.75±3.59),(28.29±4.33)],P=0.000 1, and the expressions of them were all positively correlated with CD105- MVD, r=0.540 5,P=0.005;r=0.465 2,P=0.014. CONCLUSION:The overexpressions of HIF-1α, COX-2 and CD105 may play an important role during the malignant progression of glioma and they were closely associated with tumor angiogenesis, so their cojoined de tection may better reveal biological characteristics of glioma.
出处 《中华肿瘤防治杂志》 CAS 2007年第19期1458-1461,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 胶质瘤 缺氧诱导因子-1Α 环氧化酶-2 微血管密度 免疫组织化学 glioma hypoxia inducible factor-1 cyclooxygenase-2 microvascular density immunohistochemistry
  • 相关文献

参考文献13

  • 1董伦,浦佩玉,王虎,王广秀,康春生,焦德让.星形细胞肿瘤表皮生长因子受体与p53基因的异常表达[J].中华病理学杂志,2006,35(4):232-236. 被引量:10
  • 2Lee J W, Bae S H, Jeong J W, et al. Hypoxia-inducible factor (HIF-1)α: its protein stability and biological functions[J]. Exp Mol Med, 2004,36(1) :1--12.
  • 3管晓翔,陈龙邦.环氧化酶-2在肿瘤发生中的作用机制[J].肿瘤防治杂志,2004,11(5):543-545. 被引量:5
  • 4Mineo T C, Ambrogi V, Baldi A, et al. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer[J]. Journal of Clinical Pathology, 2004,57 (6) : 591 -- 597.
  • 5Celli P, Nofrone Z, Palma L, et al. Cerebral oligodenroglioma prognostic factors and life history [J]. Neurosurgery, 1994, 35(6): 1018--1035.
  • 6Weidner N. Current pathologic methods for measuring intratumoral microvessel density with breast carcinoma and other solid tumors[J]. Breast Cancer Res Treat,1995,36(2):169--175.
  • 7Zagzag D, Nomura M, Friedlander D R, et al. Geldanamycin inhibits migration of glioma cells in vitro: A potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion[J]. J Cell Physiol,2003,196(2) : 394--402.
  • 8Kaur B, Khwaja F W, Severson E A, et al. Hypoxia and the hypoxia inducible-factor pathway in glioma growth and angiogenesis[J]. Neuro-oncol, 2005, 7(2) :134-- 153.
  • 9Tadahisa Shono, Philip J. Tofilon, Janet M. Bruner,et al. Cyelooxygenase-2 expression in Human Gliomas Prognostic Significance and Molecular Correlations[J]. Cancer Research, 2001,61 (1) :4375--4381.
  • 10New P. Cyclooxygenase in the treatment of glioma: its complex role in signal transduction[J]. Cancer Ontrol, 2004, 11 (3) : 152-- 164.

二级参考文献30

  • 1刘爱学,浦佩玉,程爱国,薛晓华,彭琼.44例人脑胶质瘤P53基因突变的研究[J].中华神经外科杂志,1996,12(6):347-350. 被引量:5
  • 2Reimer T,Herrnring C,Koczan D,et al.FasL:Fas ration-a prognostic factor in breast carcinomas[J].Cancer Res,2000,60(4):822-828.
  • 3Trifan O C,Smith R M,Thompson B D,et al.Overexpression of cyclooxygenase-2 induces cell cycle arrest[J].J Biol Chem,1999,274(48):34141-34147.
  • 4Tang X M,Sun Y I,Half E,et al.Cyclooxygenase-2 overexpression inhibits death receptor 5 expression and confers resistance to tumor necrosis factor related apoptosis inducing ligandinduced apoptosis in human colon cancer cells[J].Cancer Res,2002,62(17):4903-4908.
  • 5Zhang H,Sun XF.Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer[J].Am J Gastroenterol,2002,97 (4):1037-1041.
  • 6Nagashima H,Mori M,Sadanaga N,et al.Expression of Fas ligand in gastric carcinoma relates t1o lymph node metastasis[J].Int J Oncol,2001,18(6):1157-1162.
  • 7Buecher B,Bouancheau D,Broquet A,et al.Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines[J].Anti Cancer Res,2005,25 (1 A):225-233.
  • 8Xie G, Wang Y, Sharma M, et al. 5-Hydroxytryptamine-induced plasma extravasation in the rat knee joint is mediated by multiple prostaglandins[J]. Inflamm Res,2003,52(1):32-38.
  • 9Mitchell J A, Larkin S, Williams T J. Cyclooxygenase-2: regulation and relevance in inflammation[J].Biochem Pharmacol,1995,50(10):1535-1542.
  • 10Subbegowda R,Frommel T O. Aspirin toxicity for human colonic tumor cells results from necrosis and is accompanied by cell cycle arrest[J]. Cancer Res,1998,58(13):2772-2776.

共引文献16

同被引文献40

  • 1张咏梅,王朝卿,孙建锁,宋光耀.非小细胞肺癌组织中MRP1 mRNA和GST-π mRNA的表达及意义[J].中华肿瘤防治杂志,2007,14(12):913-916. 被引量:9
  • 2王永来,刘彩刚,陈双,黄铄.HIF-1α与VEGF在子宫内膜癌组织血管生成中的作用[J].中华肿瘤防治杂志,2007,14(15):1156-1158. 被引量:14
  • 3Shimizu M, Saitch Y, Itoh H. Immunohistochemical staining of Ha-ras oncoge product in normal, benigh, and malignant human pancreatic tissues[J]. Hum Pathol, 1990, 21(6): 607-612.
  • 4Weindener N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indication in early-stage breast careinoma[J]. J Natl Cancer Inst, 1992, 84(24) : 1875-1887.
  • 5Yamada N, Kato M, Yamashita H, et al. Enhanced expression of transforming growth factoPbeta and its type- Ⅰ and type-Ⅱ receptors in human glioblastoma[J]. Int J Cancer, 1995, 62(4): 386-392.
  • 6Samuels V, Barrett J M, Bockman S, et al. Immunocytochemi cal study of transforming growth factor expression in begin and malignant gliomas[J]. Am J Pathol, 1989, 134(4) : 894-902.
  • 7Hoeben A, Landuty B, Highley M S, et al. Vascular endothelial growth factor and angiogenesis[J]. Pharmacol Rev, 2004,56 (4) 549-580.
  • 8Friese M A, Wischhusen J, Wick W, et al. RNA interference targeting transforming growth factor beta enhance NKG2D-mediated antiglioma immune response, inhibits glioma cell migra tion and invasiveness, and abrogates tumorigenicity in vivo[J]. Cancer Res, 2004, 64(20): 7596-7603.
  • 9Josko J, Mazurek M. Transcription factors having inpact on Vascular cndethelial grouth factor (VEC-F) gene express in angiogensis [J]. Med Sci Monit. 2001,10(4) :89-98.
  • 10Kaur B, Knwaja P W, Severson E A, et al. Hypoxia and the hypox-in inducible faclor pathway in glima growth and angiogensis [J].Meuro, 2005, 7(2):134-153.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部